NTRA

Natera (NTRA) Price Target Increased by 7.38% to 102.96

The average one-year price target for Natera (NasdaqGS:NTRA) has been revised to 102.96 / share. This is an increase of 7.38% from the prior estimate of 95.88 dated March 28, 2024.

The price target is an average of many targets provided by analysts. The latest targets range from a low of 37.37 to a high of 126.00 / share. The average price target represents an increase of 14.08% from the latest reported closing price of 90.25 / share.

What is the Fund Sentiment?

There are 761 funds or institutions reporting positions in Natera. This is an increase of 61 owner(s) or 8.71% in the last quarter. Average portfolio weight of all funds dedicated to NTRA is 0.47%, an increase of 13.56%. Total shares owned by institutions increased in the last three months by 0.70% to 140,903K shares. NTRA / Natera, Inc. Put/Call Ratios The put/call ratio of NTRA is 1.01, indicating a bearish outlook.

What are Other Shareholders Doing?

NTRA / Natera, Inc. Shares Held by Institutions

Jpmorgan Chase holds 7,954K shares representing 6.59% ownership of the company. In it's prior filing, the firm reported owning 7,557K shares, representing an increase of 5.00%. The firm increased its portfolio allocation in NTRA by 29.76% over the last quarter.

Fred Alger Management holds 7,077K shares representing 5.86% ownership of the company. In it's prior filing, the firm reported owning 6,956K shares, representing an increase of 1.70%. The firm increased its portfolio allocation in NTRA by 46.56% over the last quarter.

Samlyn Capital holds 3,875K shares representing 3.21% ownership of the company. In it's prior filing, the firm reported owning 4,400K shares, representing a decrease of 13.56%. The firm increased its portfolio allocation in NTRA by 51.82% over the last quarter.

VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 3,625K shares representing 3.00% ownership of the company. In it's prior filing, the firm reported owning 3,431K shares, representing an increase of 5.33%. The firm increased its portfolio allocation in NTRA by 33.62% over the last quarter.

Farallon Capital Management holds 3,475K shares representing 2.88% ownership of the company. In it's prior filing, the firm reported owning 2,278K shares, representing an increase of 34.45%. The firm increased its portfolio allocation in NTRA by 113.86% over the last quarter.

Natera Background Information
(This description is provided by the company.)

Naterais a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a focus on women's health, oncology, and organ health. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California and Austin, Texas. It offers proprietary genetic testing services to inform obstetricians, transplant physicians, oncologists, and cancer researchers, including biopharmaceutical companies, and genetic laboratories through its cloud-based software platform.

Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.

Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.

Click to Learn More

This story originally appeared on Fintel.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.